These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19125266)

  • 21. Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Romualdi D; Giuliani M; Cristello F; Fulghesu AM; Selvaggi L; Lanzone A; Guido M
    Fertil Steril; 2010 May; 93(7):2303-10. PubMed ID: 19268929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome.
    Erensoy H; Niafar M; Ghafarzadeh S; Aghamohammadzadeh N; Nader ND
    Gynecol Endocrinol; 2019 Jan; 35(1):72-75. PubMed ID: 30182764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
    Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
    Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pattern of changes in ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle.
    Engmann L; Sladkevicius P; Agrawal R; Bekir J; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):26-33. PubMed ID: 10201083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian stromal blood flow changes after laparoscopic ovarian cauterization in women with polycystic ovary syndrome.
    Parsanezhad ME; Bagheri MH; Alborzi S; Schmidt EH
    Hum Reprod; 2003 Jul; 18(7):1432-7. PubMed ID: 12832368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.
    Agrawal R; Sladkevicius P; Engmann L; Conway GS; Payne NN; Bekis J; Tan SL; Campbell S; Jacobs HS
    Hum Reprod; 1998 Mar; 13(3):651-5. PubMed ID: 9572428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
    Kashani L; Omidvar T; Farazmand B; Modabbernia A; Ramzanzadeh F; Tehraninejad ES; Ashrafi M; Tabrizi M; Akhondzadeh S
    Psychoneuroendocrinology; 2013 Jun; 38(6):767-76. PubMed ID: 22999261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance.
    Victor VM; Rovira-Llopis S; Bañuls C; Diaz-Morales N; Castelló R; Falcón R; Gómez M; Rocha M; Hernández-Mijares A
    Eur J Endocrinol; 2015 Nov; 173(5):683-91. PubMed ID: 26320144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of myoinositol on ovarian blood flows in women with polycystic ovary syndrome.
    Özay AC; Emekçi Özay Ö; Okyay RE; Gülekli B
    Gynecol Endocrinol; 2019 Mar; 35(3):237-241. PubMed ID: 30626230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
    Abd El Aal DE; Mohamed SA; Amine AF; Meki AR
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):219-24. PubMed ID: 15653207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome.
    Iwata MC; Porquere L; Sorpreso IC; Baracat EC; Soares Júnior JM
    Rev Assoc Med Bras (1992); 2015; 61(3):215-9. PubMed ID: 26248242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metformin treatment on endometrial vascular indices in anovulatory obese/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography.
    Mohsen IA; Elkattan E; Nabil H; Khattab S
    J Clin Ultrasound; 2013 Jun; 41(5):275-82. PubMed ID: 23124626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.